COVID-19 Update: FDA recommends inclusion of Omicron BA.4/5 component for COVID-19 vaccine booster doses
WASHINGTON, D.C. — On Tuesday, the U.S. Food and Drug Administration’s independent experts on the Vaccines and Related Biological Products Advisory Committee met to publicly discuss whether a change to the current vaccine strain composition of COVID-19 vaccines for booster doses is necessary for the 2022 fall and winter seasons. The COVID-19 vaccines that […]